Basics Carisma Therapeutics, Inc. IPO Date: February 3, 2014 Sector: Healthcare Industry: Biotech Market Cap: $7.94M Activated in VL: True Average Daily Range Avg Daily Range: $0.13 | 4.50% Avg Daily Range (30 D): $0.01 | 6.46% Avg Daily Range (90 D): $0.02 | 5.68% Institutional Daily Volume Avg Daily Volume: .25M Avg Daily Volume (30 D): .54M Avg Daily Volume (90 D): .34M Trade Size Avg Trade Size (Sh.): 163 Avg Trade Size (Sh.) (30 D): 697 Avg Trade Size (Sh.) (90 D): 526 Institutional Trades Total Inst.Trades: 12 Avg Inst. Trade: $3.47M Avg Inst. Trade (30 D): $3.25M Avg Inst. Trade (90 D): $3.25M Avg Inst. Trade Volume: .57M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $4.58M Avg Closing Trade (30 D): $3.25M Avg Closing Trade (90 D): $3.25M Avg Closing Volume: 784.55K         News Jun 26, 2024 @ 6:01 PM In-Depth Examination Of 5 Analyst Recommendations ... Source: Benzinga Insights May 17, 2024 @ 3:01 PM The Analyst Verdict: CARISMA Therapeutics In The E... Source: Benzinga Insights May 9, 2024 @ 12:35 PM Carisma Therapeutics Inc. (CARM) Reports Q1 Loss, ... Source: Zacks Equity Research May 2, 2024 @ 2:01 PM Carisma Therapeutics Inc. (CARM) May Report Negati... Source: Zacks Equity Research Apr 4, 2024 @ 1:55 PM Here's Why CARISMA THERAP (CARM) Is a Great 'Buy t... Source: Zacks Equity Research Financials   TTM Q4 2024 FY 2024 Basic EPS $-.22 $-.42 $-1.46 Diluted EPS $-.22 $-.42 $-1.46 Revenue $ 3.7M $ 3.6M $ 19.6M Gross Profit $ $ $ Net Income / Loss $ -9.27M $ -17.64M $ -60.48M Operating Income / Loss $ -9.33M $ -17.86M $ -62.18M Cost of Revenue $ $ $ Net Cash Flow $ -10.17M $ -8.97M $ -59.7M PE Ratio     Splits Mar 08, 2023:   2:1